Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» aficamten
aficamten
Cytokinetics initiates trial of aficamten to treat nHCM
Cytokinetics initiates trial of aficamten to treat nHCM
Clinical Trials Arena
Cytokinetics
clinical trials
aficamten
non-obstructive hypertrophic cardiomyopathy
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
Clinical Trials Arena
Cytokinetics
clinical trials
ALS
reldesemtiv
cardiomyopathy
aficamten
Flag link:
